Pilot evaluation of the psychometric properties of a self-medication Risk Assessment Tool among elderly patients in a community setting by Lubinga, Solomon J et al.
SHORT REPORT Open Access
Pilot evaluation of the psychometric properties of
a self-medication Risk Assessment Tool among
elderly patients in a community setting
Solomon J Lubinga
1*, Ian Millar
2 and Joseph B Babigumira
3
Abstract
Background: Although community pharmacists in the United Kingdom are expected to assess elderly patients’
needs for additional support in managing their medicines, there is limited data on potentially useful assessment
tools. We sought to evaluate a 13-item assessment instrument among community dwelling elderly patients, 65
years and above. The instrument is composed of a cognitive risk sub-scale of 6 items and a physical risk sub-scale
of 7 items.
Findings: The instrument was administered to elderly patients in a survey performed in a community to the west
of Glasgow, Scotland. The survey recruited 37 participants, 31 from 4 community pharmacies and 6 patients whose
medication management tasks were managed by the West Glasgow Community Health and Care Partnership
(managed patients). Community pharmacists independently rated 29 of the 37 participants’ comprehension of, and
dexterity in handling their medicines. We assessed scale reliability, convergent validity and criterion validity. In sub-
analyses, we assessed differences in scores between the managed patients and those recruited from the
community pharmacies, and between multi-compartment compliance aid users and non-users. The instrument
showed satisfactory internal consistency (Cronbach’s alpha of 0.792 for 13-item scale). There was significant strong
negative correlation between the cognitive risk sub-scores and community pharmacists’ assessment of
comprehension (r = -0.546, p = 0.0038); and physical risk sub-scores and community pharmacists’ assessment of
dexterity (r = -0.491, p = 0.0093). The Area Under the Receiver Operator Characteristic Curve (AUC ± SE; 95%CI)
showed that the instrument had good discriminatory capacity (0.86 ± 0.07; 0.68, 0.96). The best cut-off (sensitivity,
specificity) was ≥4 (65%, 100%). In the sub-analyses, managed patients had significantly higher cognitive risk sub-
scores (6.5 versus 4.0, p = 0.0461) compared to non-managed patients. There was a significant difference in total
risk score (4 versus 2, p = 0.0135) and cognitive risk sub-score (4 versus 1.5, p = 0.0029) between users and non-
users of multi-compartment compliance aids.
Conclusions: This instrument shows potential for use in identifying elderly patients who may have problems
managing their own medicines in the community setting. However, more robust validity and reliability assessments
are needed prior to introduction of the tool into routine practice.
Background
Older people may have problems with self-management
of their medicines and exhibit unintentional noncompli-
ance, which may be caused by several risk factors such
as a higher prevalence of chronic conditions, consump-
tion of complex drug regimens, and age-associated
physical, visual, and cognitive impairment [1]. And
while studies suggest that social care support with medi-
cation management and the use of multi-compartment
compliance aids improve adherence, clinical outcomes
and quality of life [2,3], not all elderly people need such
interventions; some are self-sufficient, and others are
entirely reliant on these interventions [4]. For patients
who need interventions, multi-compartment compliance
aids may not be helpful in improving their drug man-
agement because dosage forms other than tablets and
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any medium, provided the original work is properly cited.c a p s u l e sm a yb eu n s u i t a b l ea nd patients with cognitive
problems or blindness may ingest unit-dose blister
packs [5,6]. Therefore, it is important to target interven-
tions to those who need them.
The United Kingdom National Health Service Com-
munity Pharmacy Contractual Framework and the Dis-
ability Discrimination Act require community
pharmacists to support self-care, provide a medicines
assessment and compliance service and to support
aspects of social care home services in medication man-
agement for the elderly and those with disabilities
[7-10]. As such, community pharmacists should assess
patients’ needs for additional support in managing their
medicines. Such an assessment would enable the phar-
macist to determine exactly what support a patient
would need: home delivery of prescriptions, reminder
charts, large print labels, compartmentalised compliance
aids, or social care support [8,11].
An evaluation of the Community Pharmacy Contrac-
tual Framework in England and Wales found that only
29% of pharmacies were providing medicines assessment
and compliance service and 21% provided support to
social care home services [7]. A recent study also found
that very few patients received a systematic compliance
aid assessment [12]. This may be because assessment
tools and procedures tend to be complicated and the
available tools have not undergone systematic validation
in a community setting.
A brief task-based Risk Assessment Tool (RAT) was
developed at the Department of Pharmaceutical
Sciences, University of Strathclyde in Glasgow, Scotland.
It was a 19-item instrument developed as a hospital
pharmacy-based pre-discharge assessment for elderly
patients and those recovering from stroke [[13,14];
Kusu-Orkar TG, unpublished data; Gallagher C, unpub-
lished data]. In the studies of Meland E [unpublished
data] and Yang F [unpublished data], in similar patient
samples, it was refined to a 13-item tool, by dropping 6
items that had no informational value. The refined 13-
item instrument was evaluated among rheumatoid
arthritis patients [15]. We found only one study that
evaluated the instrument in a community setting [Wen
PC, unpublished data]. In this study, the instrument was
evaluated among elderly patients (average age of 75
years) in community pharmacies. The 13-item tool how-
ever had no provision for assessing patients who were
using eye/ear/nose drops. In addition, the study
recruited participants who were “judged by the pharma-
cist to be able to handle the interview” and as such
could have recruited low risk patients.
The present paper reports on further development of
this instrument for use among elderly patients (65 years
old and above) in community settings. We evaluated a
modified version of the instrument with the aim of
determining whether it is at least as good as an experi-
enced community pharmacist, with knowledge of the
patient, in assessing older patients’ ability to manage
their own medicines. Our primary objectives were to
determine scale reliability and validate the instrument
against community pharmacists’ assessment of patients’
ability to manage their medicines. Secondarily, we
sought to compare RAT scores between patients receiv-
ing home care support with management of their medi-
cines and other community dwelling elderly patients
and between users and non-users of multi-compartment
compliance aids.
Methods
Design and settings
We performed a 4-week survey in July and August 2008.
We included participants who were at least 65 years old
and taking at least 4 different medications daily and
were either receiving social care support for administra-
tion of their medication, or using multi-compartment
compliance aids, or both. These are important risk fac-
tors for non-compliance and problems with self-man-
agement of medications, and therefore represented an
attractive group in which to test the RAT. Patients who
did not consent to participate in the survey were
excluded. We conveniently selected 4 community phar-
macies in the west of Glasgow, Scotland from which
participants were sampled. We also purposively selected
participants whose medication tasks were managed
(managed patients) by the ‘Administration of Medicines’
scheme of the West Glasgow Community Health and
Care Partnership. These were patients who had been
assessed as unable to manage their own medicines and a
social worker assumed responsibility for the medicines
management tasks. Their medicines are dispensed in
original packs with a Medication Administration Record
chart that is completed daily by the carer after assisting
the patient with his/her medicines.
Procedures
We used a modified 13-item instrument with two sub-
scales: 1) a cognitive risk sub-scale consisting of three
comprehension questions, two motivation questions and
one label-reading task and 2) a physical risk sub-scale
consisting of six dexterity questions and one coordina-
tion question (Additional file 1). The Abbreviated Men-
tal Test (AMT), a validated assessment of cognitive
function among elderly patients [16] routinely used in
clinical practice is embedded in our tool as the first
item of the cognitive risk sub-scale. For each item, parti-
cipants were assigned a score on an ordinal scale of 0, 1
and 2 in order of increasing difficulty. Total risk score
was obtained by summing all questions in the instru-
ment; cognitive risk sub-score, by summing questions 1
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- 13. A higher (worse) total score implied a higher risk
of problems with self-management of medicines. In this
study, item 13, the coordination question, was modified
to include an assessment of the ability to administer
eye/ear/nasal drops. In addition to manipulation of
liquids on to a 5 ml spoon, participants who were using
eye/ear/nasal drops regularly were asked to squeeze a
drop of normal saline eye drops onto a cap. The assess-
ment pack consisted of the following: 1) two 48 ml
amber plastic bottles, one with a screw cap and the
other with a child-proof cap; 2) a 100 ml glass bottle
with a screw cap; 3) co-codamol 50/500 mg foil strip
packs; 4) tegretol 20 mg blister packs; 5) 5 ml spoon; 6)
normal saline eye drop and 7) a compliance aid (Plus-
Pak
®) filled with sweets. The labels were printed in
Arial font, in 3 different sizes: 8, 10, and 12.
The primary author administered the instrument to
consenting participants in the community pharmacies or
their homes. Patients interviewed in pharmacies were a
combination of appointments and opportunistic inter-
views with those using the pharmacy on the day the pri-
mary author was there. Community pharmacists set up
interview appointments with suitable patients for the
days the primary author was available in the pharmacy.
Opportunistic interviews were initiated by having suita-
b l ep a t i e n t si d e n t i f i e db yt h ep h a r m a c i s to nt h ed a yt h e
primary author was in the pharmacy. Patients inter-
viewed in their homes included the managed patients
and those identified by the community pharmacists for
appointments who preferred to be interviewed in their
homes. Suitable patients were defined as those who met
our inclusion criteria, and had been under regular care
of the community pharmacist for at least 6 months
prior to the interview. These were participants for
whom the pharmacist had good knowledge of their cog-
nitive and physical ability to manage their medications.
Managed patients who met our inclusion criteria were
identified by pharmacists at the West Glasgow Commu-
nity Health and Care Partnership and appointments
w e r es e tu pb yt e l e p h o n eb yt h es e c o n da u t h o r ,ar e g i s -
tered pharmacist in the United Kingdom.
Additional data on participant age, gender, living
arrangements, medication management and multi-com-
partment compliance aid use were obtained from the
participant and community pharmacy records.
Community pharmacists, who were blinded to the
results of the instrument, were asked to independently
rate each participant’s comprehension of, and dexterity
in handling their medicines on an ordinal scale of 1 to
4, in order of increasing ability. The four pharmacists (1
from each pharmacy) involved in rating our participants
were experienced community pharmacists, each with at
least 15 years of community pharmacy practice
experience, and were the regular pharmacists in charge
of the pharmacies from which our patients were
recruited.
For criterion standards, participants were grouped into
three “able” and “unable” categories defined as follows:
1) “able overall” (community pharmacists’ score of 4 in
both comprehension and dexterity assessments) and
“unable overall” (score of less than 4 in either compre-
hension or dexterity assessments); 2) “able physically”
(score of 4 in the dexterity assessment) and “unable
physically” (score of less than 4 in the dexterity assess-
ment); and 3) “able cognitively” (score of 4 in the com-
prehension assessment) and “unable cognitively” (score
of less than 4 in the comprehension assessment). We
opted to use the community pharmacists’ assessment as
our criterion standard because there was no alternative
validated assessment tool in routine use in the partici-
pating community pharmacies.
Statistical analysis
The data was entered into a database in Microsoft Excel
2007 and exported to STATA 10.0 (Stata Corporation,
TX, USA) for analysis. Participant characteristics were
summarised, continuous data as medians and Inter-
quartile Ranges (IQR) and nominal data as percentages.
Bivarite analyses were conducted to compare character-
istics between managed participants and those whose
medicine taking was not managed (non-managed) and
between multi-compartment compliance aid users and
non-users, focussing on the non-managed participants.
We used a Kruskal-Wallis test to determine whether
there was a difference across ratings of participants’
comprehension and dexterity by pharmacist. For scale
reliability, Cronbach’s alpha was computed for the total
13-item scale, physical risk and cognitive risk sub-scales.
To investigate convergent validity, we used Spearman’s
correlation to determine the relationship between cogni-
tive and physical risk sub-scores and community phar-
macists’ comprehension and dexterity scores
respectively. Criterion validity was assessed by con-
structing Receiver Operator Characteristic (ROC) curves
for the 13-item scale, and its component physical and
cognitive risk sub-scales (against the respective criterion
standards). We computed the Area Under the Curve ±
Standard Error (AUC ± SE) and best cut-offs including
sensitivity and specificity. The best cut-offs were defined
as scores that produced the largest number of correctly
classified participants.
Bivariate analyses were conducted to compare total
risk score, cognitive and physical risk sub-scores
between managed patients and non-managed partici-
pants and between multi-compartment compliance aid
users and non-users. Bivariate analyses were performed
using the two-sample Wilcoxon Rank Sum test for
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Fisher exact test for categorical data.
Ethics statement
All participants provided written informed consent. The
Ethics Committee of the Department of Pharmaceutical
Sciences, Strathclyde Institute of Pharmacy and Biome-
dical Sciences approved the study protocol. All proce-
dures complied with the Declaration of Helsinki.
Results
Participant characteristics
Thirty-seven participants met the inclusion criteria and
completed the interview. Of these, 8 were interviewed at
home: the 6 managed patients and 2 others by prefer-
ence. Of the 29 patients interviewed from the pharma-
cies, 6 (20.7%) were interviewed from the first two
pharmacies each, 4 (13.8%) from the third pharmacy
and 13 (44.8%) from the fourth. Overall, the median
(IQR) age was 76 (72, 82) years and number of medi-
cines taken was 8 (6, 10). About half (51.4%) of the par-
ticipants were male. Twenty-two (59.4%) lived alone and
of these 12 (54.5%) received routine social care support
at their homes. The majority (70.3%) managed their
medicines by themselves. Eighteen (48.6%) participants
used multi-compartment compliance aids. Table 1 and
Table 2 present participant characteristics factored for
managed and non-managed patients and for multi-com-
partment compliance aid use (considering the 31 non-
managed participants only) respectively. There were no
significant differences in participant characteristics when
these groups were compared.
Overall RAT scores
Overall, total risk score, cognitive risk sub-score and
physical risk sub-score ranged from 0-15, 0-9 and 0-7
respectively. Participants had a median (IQR) total risk
score of 4.0 (2.0, 6.3), cognitive risk sub-score of 3.0
(1.0, 5.3) and physical risk sub-score of 0 (0, 2).
Scale reliability and validity
Cronbach’s alphas were 0.792, 0.679 and 0.813 for the
13-item, cognitive risk, and the physical risk sub-scales
respectively. Dexterity items “C a no p e n4 8m la m b e r
plastic with screw cap” and “Can open 100 ml glass bot-
t l ew i t hn o r m a lc a p ” were constant in our analysis sam-
ple and were therefore dropped from the analysis (Table
3). Further item analysis of the cognitive risk sub-scale
showed that if motivation item 1, “Do you think your
medicines are necessary for your health?” were removed,
Cronbach’s alpha rose to 0.712.
We obtained community pharmacists’ assessments for
the 29 (78.4%) participants who were interviewed in the
pharmacies. There was no statistically significant differ-
ence in pharmacist ratings of participants’ comprehen-
sion (c
2 with ties = 1.453, p = 0.6932) and dexterity (c
2
with ties = 1.724, p = 0.6316) by pharmacist. 15 (51.7%)
participants were classified as “able cognitively”,1 6
(55.2%) as “able physically” and 9 (31%) as “able overall”.
There was a significant negative correlation between
cognitive risk sub-score and the community pharma-
cists’ assessment of comprehension (r = -0.546, p =
0.0038) and the physical risk sub-score and community
pharmacists’ assessment of dexterity (r = -0.491, p =
0.0093).
AUC ± SE (95% CI) were 0.71 ± 0.10 (0.53, 0.87) for
the cognitive risk sub-scale (Figure 1), 0.71 ± 0.89 (0.53,
0.87) for the physical risk sub-scale (Figure 2) and 0.86
± 0.07 (0.68, 0.96) for the total 13-item tool (Figure 3).
The best cut-off points (sensitivity, specificity) were ≥4
(50.0%, 86.7%) for the cognitive risk sub-scale, ≥2
(46.2%, 93.8%) for the physical risk sub-scale, and ≥4
Table 1 Profile of participants factored for medication management (N = 37)
Parameter Managed (N = 6) Non-managed (N = 31) p-value
Age in years, median (IQR) 81 (77, 87) 76 (72, 80) 0.154
Number of regular medicines 8 (6, 9) 8 (6, 10) 0.984
Gender, n (%)
Male 3 (15.8) 16 (84.2) 0.942
Female 3 (16.7) 15 (83.3)
Living arrangement, n (%)
Live alone 0 (0.0) 10 (100) 0.100
Live alone with help 4 (33.3) 8 (66.7)
Do not live alone 2 (13.3) 13 (86.7)
Use of multi-compartment compliance aid, n (%)
Do not use 4 (15.8) 16 (84.2) 0.590
Use a dosett box 0 (0) 4 (100)
Use the PlusPak
® 3 (21.4) 11 (78.6)
IQR - Interquartile Range
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73.41% and 75.86% respectively, correctly classified.
Comparative sub-analyses
Although managed participants had worse scores com-
pared to the other community dwelling patients, only
the cognitive risk sub-score difference was statistically
s i g n i f i c a n t( T a b l e4 ) .T h ed i f f e r e n c ei nt o t a lr i s ks c o r e
approached statistical significance. The total risk score
and cognitive risk sub-scores were significantly worse
among multi-compartment compliance aid users com-
pared to the non-users (Table 5).
Discussion
Overall RAT scores
Typical scores for the participants in our study were better
than those in the prior studies that employed the instru-
ment in elderly hospitalised patients (with or without
stroke) and those with rheumatoid arthritis [[13-15];
Kusu-Orkar TG, unpublished data; Gallagher C, unpub-
lished data; Meland E, unpublished data; Yang F, unpub-
lished data]. These patients had worse total scores (>10)
possibly because elderly hospitalised patients tend to be
more debilitated than community dwelling patients. Addi-
tionally, stroke is commonly associated with both cognitive
and physical impairment and rheumatoid arthritis is asso-
ciated with significant dexterity problems. Though our
scores were closer to those of Wen [unpublished data],
who reported a median (IQR) total risk scores in patients
recruited in community pharmacies of 2 (2, 3), they were
slightly worse. This may be due to differences in study
participant recruitment. The 6 (16%) managed partici-
pants, who had significantly worse total risk scores and
cognitive risk sub-scores than the other participants, may
have contributed to worse overall scores in our study. In
addition, in the study by Wen [unpublished data],
Table 2 Profile of non-managed participants (N = 31) factored for compliance aid use
Parameter Users (N = 15) Non-users (N = 16) p-value
Age in years, median (IQR) 81 (77, 87) 76 (72, 80) 0.766
Number of regular medicines 8 (6, 9) 8 (6, 10) 0.339
Gender, n (%)
Male 9 (15.8) 7 (84.2) 0.366
Female 6 (16.7) 9 (83.3)
Living arrangement, n (%)
Live alone 5 (50.0) 10 (50.0) 0.560
Live alone with help 5 (62.5) 8 (37.5)
Do not live alone 5 (38.5) 13 (62.5)
Daily management of medications at home, n (%)
Self 11 (45.8) 13 (54.2) 0.311
Assistance from professional carer 2 (100) 0 (0.0)
Assistance from relatives/friends 2 (40.0) 3 (60.0)
IQR - Interquartile Range
Table 3 Item-rest correlation and Cronbach’s alpha if item deleted for the 13 item RAT (non-managed patients only,
N = 31)
RAT Item Item-rest correlation Cronbach’s alpha if item deleted
Abbreviated Mental Test 0.499 0.774
What medication do you take at the moment? 0.374 0.801
Have there been any changes in your medication recently? 0.517 0.774
Do you think your medicines are necessary for your health? 0.054 0.804
How confident are you about taking your medicines on your own? 0.229 0.797
Reading three sample labels of increasing font size (Arial: 8, 10, 12) 0.691 0.753
Can open 48 ml amber plastic with screw cap
a --
Can open 48 ml amber plastic with childproof cap 0.460 0.779
Can open 100 ml glass bottle with normal cap
a --
Can pop open blister packs 0.486 0.782
Can open foil strip of tablet 0.627 0.757
Manages to take out tabs from PlusPack
® 0.531 0.784
Fine manipulation - 5 ml spoon and/or Dropper bottle 0.650 0.755
a constant in study sample and dropped from the analysis
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Figure 1 Receiver operator curve for cognitive risk sub-scale.
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Figure 2 Receiver operator curve for physical risk sub-scale.
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Page 6 of 10community pharmacists made a prior judgement on the
ability of the participant to handle the interview as an
inclusion criterion. As such, a degree of selection bias was
unavoidable as the pharmacist could have selected partici-
pants who were ‘able’ physically and cognitively to partici-
pate in the interview, translating into better scores. In our
study, a majority (29, 78.4%) of participants were recruited
as they came into the pharmacies to collect their prescrip-
tions, skipping the need for the pharmacists’ judgement
prior to the interview.
Scale reliability and validity
Internal consistency was used as a measure of scale
reliability. The Cronbach’s alphas obtained for the 13-
item scale and the physical risk sub-scale were above
the indicative value of 0.70 for acceptable internal con-
sistency [17]. If used alone, the cognitive risk sub-scale
had a value lower that 0.70, indicating that it might not
be reliable. However, internal consistency is improved
by removal of motivation item 1, “Do you think your
medicines are necessary for your health?” This item
might be considered for removal if the cognitive risk
sub-scale is to be used alone. Dexterity items “Can open
48 ml amber plastic with screw cap” and “Can open 100
ml glass bottle with normal cap” that were constant in
our study sample should probably be considered for
removal, as they carry no discriminatory value. This is
consistent with the fact that all participants in our study
successfully completed these tasks.
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Figure 3 Receiver operator curve for the overall Risk Assessment Tool.
Table 4 Comparison of scores between managed and
non-managed participants
Parameter RAT score, median (IQR) p-value
Managed
(N = 6)
Non-managed
(N = 31)
Total risk score 6.5 (4, 12) 3 (2, 5) 0.0710
Cognitive risk sub-score 6.5 (4, 8) 3 (1, 4) 0.0461
Physical risk sub-score 1 (0, 3) 0 (0, 2) 0.4362
RAT - Risk Assessment Tool; IQR - Interquartile Range; managed patients - on
managed level of care of the Administration of Medicines scheme of the West
Glasgow Community Health and Care Partnership (WGCHCP)
Table 5 Comparison of RAT scores between multi-
compartment compliance aid users and non-users
(non-managed patients only, N = 31)
Parameter RAT score, median (IQR) p-value
Users
(N = 15)
Non-users
(N = 16)
Total risk score 4 (3.20, 6.80) 2 (1.00, 3.60) 0.0135
Cognitive risk sub-score 4 (3.00, 5.80) 1.5 (1.00, 2.60) 0.0029
Physical risk sub-score 0 (0.00, 1.80) 0 (0.00, 1.60) 0.7286
RAT - Risk Assessment Tool, IQR - Interquartile Range
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data], a strong negative correlation between the instru-
ment scores and the community pharmacists’ assess-
ment shows that there is agreement between the
community pharmacists’ assessments and the instru-
ment. The ROC analysis (the AUC and 95% CI
obtained) indicates that the full 13-item scale has good
discriminatory capability. However, the wide 95% CI for
the AUC for sub-scales with the lower bounds tending
towards 0.5 imply that in some patients, the sub-scales
used alone may not have good discriminatory capability.
We found that a cut-off (sensitivity, specificity) total risk
score of ≥4 (65%, 100%) would be the best value for
screening purposes. The cut-offs obtained in our study
were much lower than those in earlier studies among
hospitalised elderly patients [13,14] and those with rheu-
matoid arthritis [15]. These conditions present unique
cognitive and dexterity challenges to patients. In addi-
tion, while we used a community pharmacist’s assess-
ment as our criterion standard, these studies utilised a
Global Clinical Assessment, which is a more commonly
used assessment tool in the hospital setting. Though
comparable, our 13-item cut-off is slightly higher than
that of Wen [unpublished data] because our participants
generally had worse scores.
Comparative sub-analyses
Differences in scores between managed patients and
other patients only resulted from the cognitive risk sub-
scale. Managed participants had good physical risk
scores, similar to other community dwelling elderly
patients, implying that they are able to manage adminis-
tration tasks just as well. Inability to self-manage medi-
cines appears to have been the result of cognitive
impairment (such as forgetfulness), which has been
associated with unintentional non-adherence in the
elderly [18,19]. Our results suggest that patients with
poor scores on the cognitive domain of the instrument
should be considered for social care support with medi-
cation management.
Only total risk score and cognitive risk sub-score were
significantly worse for multi-compartment compliance
aid users compared to non-users, suggesting that multi-
c o m p a r t m e n tc o m p l i a n c ea i d ss h o u l db ec o n s i d e r e di n
elderly patients with cognitive impairment, as a memory
prompt, on condition that they are physically capable of
self-administration. In this way, a patient who scores
poorly on both physical and cognitive sub-scales would
not be considered a candidate for multi-compartment
compliance aid use and alternative means of medication
support would be sought. However a patient who has
poor scores on the cognitive sub-scale and good scores
on the physical sub-scale would benefit from multi-com-
partment compliance aid use.
There are strengths inherent in the use of this instru-
ment. It is a multidimensional instrument, covering sev-
eral factors associated with the inability of patients to
self-manage their medicines. The short time (15 to 20
minutes) it takes to conduct the assessment should be a
welcome positive for practitioners as well as patients.
Item 1, in the cognitive domain is based on a validated
measure of cognitive function, the Abbreviated Mental
Test [16]. The physical domain is strong as all items are
based on completion of tasks related to actually taking
medicines. In practice, it couldh e l pi d e n t i f yr e a lp h y s i -
cal limitations that patients may have in handling their
medicines for example, failure to read standard size
labels or opening child resistant caps, such that tailored
interventions may be designed, for example, use of lar-
ger sized labels, replacing child resistant caps with
ordinary screw caps. Generally, the instrument is easy to
use and does not require pharmaceutical expertise to
administer effectively. With a little training, social carers
could use it to target appropriate support to those in
need. They could use the instrument to bring both phy-
sical and cognitive limitations to medication manage-
ment to the attention of pharmacists and other
h e a l t h c a r ew o r k e r s .I tc a na l s ob eu s e da tt h ep o i n to f
discharge from the hospital to help guide decisions
about the most appropriate discharge destination as well
as medication management support for individual
patients.
Study limitations
Our study was limited by a small sample size, which
could have compromised our ability to make definitive
statements on the psychometric properties of the instru-
ment. In addition, the comparison of scores between
managed and non-managed patients is limited by the
fact that there were only 6 managed patients. Commu-
nity pharmacists set up opportunist interviews and
appointments. As such we did not gather the data how
many they approached to make the 31 community parti-
cipants; and we could only trace 6 managed participants
through the WGCHCP records. And because we neither
used a pre-validated instrument for the community
pharmacists’ assessments, nor conducted inter-rater
reliability across pharmacists, further studies are needed
to validate this tool against more robust instruments.
We used a conservative definition of polypharmacother-
apy (4 or more medicines). Our results showed that the
median (IQR) number of medicines used by our patients
was much higher, 8 (6-10), ranging from 4-21. Our
s t u d yt h e r e f o r em i g h th a v eb e e nb i a s e db yl o w e rr i s k
patients in terms of the number of medicines taken.
Although our study demonstrated an association
between cognitive risk sub-scores and both multi-com-
partment compliance aid use and social care support
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between patients in the physical risk domain of the tool.
Therefore we are unable to determine, using the tool,
exactly which patients would be candidates for either
social care support or multi-compartment compliance
aids. In spite of this, we found that typical scores in
“managed” participants are worse than those who use
multi-compartment compliance aids (6.5 versus 4.0). We
can therefore discern that patients with much worse
scores may be considered for social care support, as
opposed to multi-compartment compliance aids.
There are limitations inherent in the tool itself. The
questions concerning motivation ("do you think your
medicines are necessary for your health?” and “how con-
fident are you about taking your medicines on your
own?”)r e l yo nt h ep a r t i c i p a n tp r o v i d i n ga nh o n e s t
answer. The question “what medications do you take at
the moment?” assesses people’s knowledge of their med-
icines. There are various dimensions to a patient’s
knowledge of their medicines, and the evidence linking
knowledge of medicines to adherence and ability to self-
manage medicines is at best conflicting [1].
Conclusions
The instrument shows potential for use in identifying
the limitations that older patients in the community
m a yh a v ew i t hm a n a g i n gt h e i rmedicines. With further
modifications such as removal of items without discri-
minatory capacity, validation with a larger sample size
and against more robust self-medication management
assessment instruments, and determination of optimal
cut-offs to distinguish between patients requiring home
care medication management support or compliance
aids, the tool could be considered for introduction into
routine community practice.
Additional material
Additional file 1: 13-item self-medication Risk Assessment Tool.
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